Podcast Host Chris Leidli
Rx for Biotech
"Rx for Biotech" is a healthcare education podcast dedicated to helping patients, caregivers, and healthcare professionals understand the rapidly evolving world of advanced therapies - and how patients can access them. From cell therapies and gene therapies to radiopharmaceuticals, immunotherapies, and next-generation treatments for cancer and autoimmune disease, this channel bridges the gap between breakthrough science and real-world patient care. Hosted by Chris Leidli, founder of Genoplex and longtime host of the Rx for Biotech podcast, each episode features conversations with:• Biotech and...
Be sure to visit the podcast's website and support the creator: soundcloud.com
Author
Podcast Host Chris Leidli
Category
Podcast website
Latest episode
Nov 10, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
The Alpha Edge: Perspective Therapeutics on the Future of Theranostics and Radiopharmaceutical Therapies 09.09.2025 37:02
In this episode of Tc for Biotech, host Chris Leidli sits down with Thijs Spoor, CEO of Perspective Therapeutics, to unpack the future of radiopharmaceuticals for the treatment of cancer. This conversation goes beyond the science to explore the infrastructure and strategy that determines success in bringing target cancer therapies to patients.
Harnessing the Immune System: PDS Biotech’s NextGen Approach to Cancer Treatment 21.08.2025 39:43
In this episode of Rx for Biotech, host Chris Leidli sits down with Dr. Frank Bedu-Addo, CEO of PDS Biotechnology, to discuss how the company is reimagining immunotherapy with its proprietary Versamune® T-cell activating platform.
How Nonacus is Changing Cancer Detection with CEO, Jeff Bousfield 05.08.2025 26:54
Early cancer detection doesn't have to mean invasive tests. In this podcast episode, we sit down with Jeff Bousfield, CEO of Nonacus Cancer Diagnostics, to explore how his UK-based company is revolutionizing precision cancer diagnostics with a powerful suite of non-invasive tools. Jeff shares the human story behind the science and why he believes the future of cancer care starts with precision dia...
Hope in Hard Places: A Potential New Option for Patients with Pancreatic Cancer 24.07.2025 43:00
Metastatic pancreatic cancer remains one of the deadliest cancers, but a new approach is taking shape - and it's showing promise in early clinical studies. In this episode, Dan Schmitt, President and CEO of Actuate Therapeutics, shares how elraglusib, an investigational targeted therapy, may provide a new option for patients with metastatic pancreatic cancer. We explore the urgent unmet need and w...
How Mesenchymal Stem Cells Are Shaping the Future of Medicine with Dr. Kilian Kelly 03.06.2025 29:05
In this podcast episode, Dr. Kilian Kelly, CEO of Cynata Therapeutics, discusses the future of regenerative medicine! Discover how mesenchymal stem cells (MSCs)—powerful cells that repair and regenerate tissues—are revolutionizing treatments for a range of diseases. Dr. Kelly shares insights on Cynata’s groundbreaking Cymerus™ platform and the exciting potential of MSC therapies.
Patient Perspective with CAR-T Cell Therapy Advocate, Brad Watt 08.05.2025 38:18
Our guest in this podcast episode is lymphoma survivor and CAR-T cell therapy patient advocate, Brad Watts. In this episode, Brad shares his personal story battling lymphoma at the young age of 29 along with his experience receiving an innovative cell therapy. This field is transforming lives and Brad is living proof of this potential.
How AI is Transforming Job Search and Recruiting in Life Sciences and Technology 24.04.2025 32:11
AI is transforming job search, recruiting and hiring practices. Our guest in this podcast episode is Steve Swan, Practice Leader at The Swan Group. Steve is an Executive Recruiter specializing in technology for the Pharmaceutical and Biotech Industry. In this episode Steve shares his insights on how AI is transforming the hiring process.
From Nigeria to the USA: Gene Therapy Journey with Sickle Cell Warrior, Jimi Olaghere 24.03.2025 36:48
Gene therapy offers significant hope for treating sickle cell disease (SCD), a genetic disorder caused by a single mutation in the hemoglobin gene. Recent advancements have led to promising developments and FDA approvals, but challenges remain. In this podcast episode, gene therapy survivor, Jimi Olaghere, shares his journey and offers hope to others with his inspirational message and through his...
The Promise of Dendritic Cell Vaccines with Diakonos Oncology President and COO Jay Hartenbach 02.03.2025 24:48
In this podcast episode, hear from Diakonos Oncology President and Chief Operating Officer Jay Hartenbach, who provides an update on the company's innovative dendritic cell vaccine therapy designed to tackle some of the most challenging cancers, including glioblastoma and pancreatic cancer
New Therapies for Brain Cancer with Neurosurgeon Thomas Chen, CEO of NeOnc 06.01.2025 31:53
Dr. Thomas Chen is a world-renowned neurosurgeon, Director of Surgical Neuro-Oncology at the University of Southern California, and the founder and CEO of NeOnc Technologies. In this podcast episode we discuss the company’s unique approach to treating glioblastoma and other aggressive brain cancers.
From Meditation to Music: Exploring AI's Boundless Potential with Sreekanth Gopi 18.12.2024 32:20
Our guest in this podcast episode is Sreekanth Gopi, a leader in generative AI and machine learning. Sreekanth has applied AI to fields as diverse as physiological monitoring, meditation, and even generating multi-track Indian classical music. He’s published award-winning research on EEG spectral analysis and adaptive quiz generation using large language models, participated in over 12 AI hackatho...
How Arvinas is Transforming Cancer and Neuroscience Therapies: An Interview with CBO, Randy Teel, PhD 03.12.2024 35:44
Arvinas is a biotech company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. In this podcast episode, Dr. Randy Teel discusses the company's PROTAC protein degrader technology platform and its pipeline of clinical-stage assets, with a focus on vepdegestrant, the company's lead asset that is being co-developed together with partner Pfizer, for...
The Future of Healthcare: Insights from the Biggest Health Tech Conference of 2024 12.11.2024 26:10
HLTH brings together all the ecosystem stakeholders each year to discuss the innovations that will help solve some of healthcare's biggest challenges. In this podcast episode, Noe Gutierrez, the Head of Commercial Operations at Genoplex, Inc., shares many of the key themes and insights from the biggest health tech conference of 2024.
How NGGT is Pioneering the Next Wave of Gene Therapies 10.10.2024 40:11
Next Generation Gene Therapies is developing novel gene therapies for the treatment of many rare diseases. In this podcast episode, the company's Co-Founder and Chief Operating Officer, Guang Qu, discusses how the company's dual-functional vector tech platform is being used to target many diseases.
Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker 18.09.2024 38:19
Immunotherapies continue to redefine treatment for many types of cancer and one of the first immunotherapies approved and used clinically as a therapeutic is Interleukin-2, or IL-2. Aulos Bioscience is an immuno-oncology company that has developed AU-007, a potential best-in-class IL-2, that improves on many of the other IL-2 products in development. In this episode, we discuss the promise of AU-0...
Left Behind: Addressing Health Equity for the Rare Disease Patient Community 09.09.2024 20:58
In this podcast episode, we discuss the importance of addressing health equity for the rare disease community with Tamar Thompson, Head of Corporate Affairs at Alexion, AstraZeneca Rare Disease. Tamar discussed her efforts to champion health policy, advocacy, equity, and awareness for rare diseases. Link to NMOSD video mentioned in episode: https://www.youtube.com/playlist?list=PLJQx_6LtucSB9GGeiW...
Emerging Cell Therapies for Blood Cancers with Arcellx CMO, Chris Heery, MD 05.09.2024 30:21
In this podcast episode, we sit down with Christopher Heery, the Chief Medical Officer at Arcellx to learn about the company's pipeline and lead cell therapy, anitocabtagene autoleucel, or anito-cel, that is in development for multiple myeloma. Multiple myeloma, like lymphoma and leukemia are types of cancer that start in your blood cells.
Unlocking AI In Oncology with James Zou, PhD 27.08.2024 24:40
In this podcast episode, Dr. James Zou, Associate Professor of Biomedical Data Science and Faculty DIrector of the AI for Health department at Stanford University, shares current use cases for AI in healthcare and oncology and discusses how we can overcome challenges with LLMs to unlock the full potential of AI.
Revolutioning Patient Access: An Interview with Genoplex CTO, Shoukri Kattan 22.08.2024 44:21
In this episode, Genoplex Founder and CEO, Chris Leidli, and CTO, Shoukri Kattan, take a dive deep into their shared passion for health, wellness, and longevity, and explore how technology is revolutionizing patient access to advanced therapies. Chris and Shoukri discuss the groundbreaking work happening at Genoplex, including how the company's Advanced Therapy Connect digital platform is transfor...
Building a Leading Cell Therapy Service Line with Robb Richards - Penn Medicine 14.08.2024 24:33
Our guest for this podcast episode is Robb Richards, Corporate Director of Cell Therapy and Transplant at University of Pennsylvania, Penn Medicine. In this episode, we discuss how Penn Medicine is working to improve patient access to cellular therapies and how technology has evolved to streamline operational and clinical workflows to enhance patient experience.
How MedStack helps Health Tech companies with Compliance and Data Privacy 28.07.2024 41:28
Our guest for this episode is Balaji Gopalan, CEO and Co-Founder of MedStack where we discuss how MedStack's tech stack is enabling digital health start-ups to be healthcare data compliant. MedStack streamlines compliance with out-of-the-box HIPAA controls and ready-to-use privacy policies, enabling the faster and more cost-effective development of digital health applications. With built-in securi...
How NervGen is Developing Novel Treatments to Repair Damage to the Nervous System 09.07.2024 20:00
Our guest for this podcast episode is Mike Kelly, President & CEO of NervGen Pharma. NervGen is a clinical-stage biotech company at the forefront of developing treatments that empower the nervous system to repair itself following damage from injury or disease.
ASCO 2024 Recap, ADCs, Cell Therapies and RLTs 13.06.2024 18:53
In this podcast episode, your host, Chris Leidli, MS, MBA, goes beyond the ASCO 2024 headlines and puts a spotlight on the new clinical data for advanced therapies you don't want to miss.
ASGCT 2024 Abstracts Preview 23.04.2024 43:23
In this episode, we preview the top American Society of Gene and Cell Therapy (ASGCT) 2024 annual meeting abstracts with guests Dr. Emily Walsh Martin from Tremont Therapeutics Consulting and Lynnea Olivarez, Incoming Chair of the ASGCT Communications Committee.
Update on Evolving Tech and Data Standards to Improve Cell Therapy Informatics 28.03.2024 36:05
Over the years, electronic health records (EHRs) have revolutionized medical practice, digitizing patient data and streamlining care. But the current systems are not well suited to support collection of real-world data or the tracking of longitudinal outcomes across patient populations. This is particularly true for hematopoietic stem cell transplant and cellular therapies. Our special guest, Dr....
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.